Carcinoembryonic Antigen (CEA)
|Product Name||Carcinoembryonic Antigen|
|Source||Human Liver Metastases|
|Purity||> 95% (SDS-PAGE)|
|Protein||Report mg/mL (OD280 and Roche EIA)|
|Purity Note||Low cross contamination from other cancer antigens|
|Form||Solution in 20 mM Tris, 100 mM sodium chloride, pH 7.4 with 0.05% sodium azide.|
|Synonyms||CEA, Carcinoembryonic antigen-related cell adhesion molecule 5, Meconium antigen 100, CD_antigen=CD66e|
|Gene||CEACAM5, CD66e, CEA|
Lee Biosolutions is a producer and supplier of high purity human Carcinoembryonic Antigen (CEA), a marker for bowel cancer, colorectal carcinoma, lung cancer research and diagnostic manufacturing.
Custom preparations, technical support, bulk quantities and aliquoting available, email Info@leebio.com for more details.
Serum tumor marker human Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production stops before birth. Therefore, serum tumor marker human CEA is not usually present in the blood of healthy adults, although levels are raised in heavy smokers.
Associated Cancer Types: Gastrointestinal, Cervix, Lung, Ovarian, Breast and Urinary Tract Cancer